ITOS logo

iTeos Therapeutics (ITOS)

Profile

Full Name

iTeos Therapeutics, Inc.

Ticker Symbol

ITOS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

http://www.iteostherapeutics.com

Employees

173

Key Details

Price

$6.18(-0.59%)

Market cap

$236.16M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$35.00M(+177.89% YoY)

Annual EPS

-$3.32(-5.40% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.18
ITOS price is $6.18

30-Day Relative Volume

0.03
ITOS 30-day relative volume is 0.03

Price Performance

Price Today change

-0.59%
ITOS price is down -0.59% today

Price YTD change

-19.49%
ITOS price is down -19.49% since January 1st

Price 1-year change

-42.11%
ITOS price is down -42.11% year-on-year

Price 3-year change

-81.07%
ITOS price is down -81.07% over the past 3 years

Price Range

Price All-time high

$52.43
ITOS price is currently -88.21% below its historical high of $52.43

Price 3-year low

$4.80
ITOS price is currently +28.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$236.16M
ITOS market capitalization is $236.16 million

Market cap 3-year change

-79.64%
ITOS market capitalization is down -79.64% over the past 3 years

Market cap All-time high

$1.69B
ITOS market capitalization is currently -86.01% below its historical high of $1.69 billion

Market cap sector rank

59.95%
ITOS market capitalization is higher than 59.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.56%
ITOS shares outstanding is up +6.56% year-on-year

Shares Outstanding 3-Year Change

+7.52%
ITOS shares outstanding is up +7.52% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.90
ITOS beta is 0.90

200-day SMA

$10.17
ITOS price is currently -39.19% below its 200-day simple moving average

50-day SMA

$6.74
ITOS price is currently -8.27% below its 50-day simple moving average

RSI

51.28
ITOS 14-day relative strength index is 51.28

Volume

0.03
ITOS 30-day relative volume is 0.03

ATR

$0.41
ITOS average true range is $0.41

10-day Historical Volatility

87.39%
ITOS 10-day historical volatility is 87.39%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$35.00M
ITOS annual revenue is $35.00 million

Revenue Analysts estimate

$7.48M
ITOS annual revenue is currently +367.85% higher than the consensus analysts' forecast

Revenue 1-year change

+177.89%
ITOS annual revenue is up +177.89% year-on-year

Revenue Sector rank

42.11%
ITOS annual revenue is higher than 42.11% of companies in Healthcare sector

EPS

EPS

-$3.32
ITOS annual earnings per share is -$3.32

EPS Analysts estimate

-$3.77
ITOS annual earnings per share is currently -12.00% lower than the consensus analysts' forecast

EPS 1-year change

-5.4%
ITOS annual earnings per share is down -5.4% year-on-year

EPS Sector rank

27.02%
ITOS annual earnings per share is higher than 27.02% of companies in Healthcare sector

Profit

Gross profit

-
ITOS annual gross profit value is unknown

Gross margin

-
ITOS annual gross profit margin value is unknown

Operating profit

-$154.32M
ITOS annual operating income is -$154.32 million

Operating margin

-440.93%
ITOS annual operating profit margin is -440.93%

Net income

-$134.41M
ITOS annual net profit is -$134.41 million

Net margin

-384.04%
ITOS annual net profit margin is -384.04%

Expenses

Total expenses

$189.32M
ITOS annual total expenses is $189.32 million

Operating expenses

$189.32M
ITOS annual total operating expenses is $189.32 million

Cost of goods sold

-
ITOS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$49.08M
ITOS annual SGA is $49.08 million

Depreciation and amortization

$1.24M
ITOS annual depreciation & amortization is $1.24 million

Interest expense

-
ITOS annual interest expense value is unknown

Income tax

$14.07M
ITOS annual income tax is $14.07 million

EBIT & EBITDA

EBIT

-$154.32M
ITOS annual earnings before interest & taxes is -$154.32 million

EBITDA

-$153.09M
ITOS annual EBITDA is -$153.09 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$686.98M
ITOS annual total assets is $686.98 million

Non current assets

$177.44M
ITOS annual long term assets is $177.44 million

Current assets

$509.54M
ITOS annual total current assets is $509.54 million

Cash and cash equivalents

$142.13M
ITOS annual cash & cash equivalents is $142.13 million

Accounts receivable

-
ITOS annual accounts receivable value is unknown

Inventory

-
ITOS annual inventory value is unknown

Liabilities

Total liabilities

$96.68M
ITOS annual total liabilities is $96.68 million

Long term liabilities

$56.32M
ITOS annual total long term liabilities is $56.32 million

Current liabilities

$40.36M
ITOS annual total current liabilities is $40.36 million

Accounts payable

$8.50M
ITOS annual accounts payable is $8.50 million

Debt

Total debt

$5.10M
ITOS annual total debt is $5.10 million

Total debt 1-year change

-15.88%
ITOS annual total debt is down -15.88% year-on-year

Long term debt

$3.76M
ITOS annual long term debt is $3.76 million

Short term debt

$1.34M
ITOS annual short term debt is $1.34 million

Equity & Capital

Shareholders equity

$590.29M
ITOS annual stockholders equity is $590.29 million

Book value

$590.29M
ITOS annual book value is $590.29 million

Retained earnings

-$9.78M
ITOS annual retained earnings is -$9.78 million

Working capital

$469.18M
ITOS annual working capital is $469.18 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$98.18M
ITOS annual cash flow from operations is -$98.18 million

Cash from operations 1-year change

+5.37%
ITOS annual cash flow from operations is up +5.37% year-on-year

Cash from investing

-$131.15M
ITOS annual cash flow from investing activities is -$131.15 million

Cash from investing 1-year change

-280.5%
ITOS annual cash flow from investing activities is down -280.5% year-on-year

Cash from financing

$122.24M
ITOS annual cash flow from financing activities is $122.24 million

Cash from financing 1-year change

+10883.02%
ITOS annual cash flow from financing activities is up +10883.02% year-on-year

CAPEX

CAPEX

$1.63M
ITOS annual capital expenditures is $1.63 million

CAPEX 1-year change

-44.94%
ITOS annual capital expenditures is down -44.94% year-on-year

Free Cash Flow

Free cash flow

-$99.81M
ITOS annual free cash flow is -$99.81 million

Free cash flow 1-year change

+6.47%
ITOS annual free cash flow is up +6.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ITOS annual gross profit margin value is unknown

Operating margin

-440.93%
ITOS annual operating profit margin is -440.93%

Net margin

-384.04%
ITOS annual net profit margin is -384.04%

ROA & ROE

ROA

-19.85%
ITOS annual return on assets is -19.85%

ROE

-23.07%
ITOS annual return on equity is -23.07%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ITOS price to earnings ratio value is unknown

PE ratio Sector rank

-
ITOS price to earnings ratio is unknown

PB Ratio

PB ratio

0.40
ITOS price to book ratio is 0.40

PB ratio Sector rank

27.1%
ITOS price to book ratio is higher than 27.1% of companies in Healthcare sector

PS Ratio

PS ratio

-
ITOS price to sales ratio value is unknown

PS ratio Sector rank

-
ITOS price to sales ratio is unknown

Enterprise value

Enterprise value

$99.12M
ITOS enterprise value is $99.12 million

Enterprise value Sector rank

50.29%
ITOS enterprise value is higher than 50.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.65
ITOS EV/EBITDA is -0.65

EV/EBITDA Sector rank

48.43%
ITOS EV/EBITDA is higher than 48.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.62
ITOS annual current ratio is 12.62

Quick ratio

-
ITOS annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ITOS annual debt to equity ratio is 0.00

Interest coverage ratio

-
ITOS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ITOS piotroski f-score value is unknown

Altman Z-Score

1.57
ITOS altman z-score is 1.57

Analyst ratings

Recent major analysts updates

Mar 6, 25 Wells Fargo
Overweight
Mar 6, 25 JP Morgan
Overweight
Mar 6, 25 HC Wainwright & Co.
Buy
Jan 16, 25 HC Wainwright & Co.
Buy
Dec 19, 24 Wells Fargo
Overweight
Dec 13, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Wells Fargo
Overweight
Aug 12, 24 JP Morgan
Overweight

Institutional Ownership

Similar stocks

RCEL logo
AVITA Medical (RCEL)
Atlantic International (ATLN)
ACB logo
Aurora Cannabis (ACB)
ABEO logo
Abeona Therapeutics (ABEO)
CMPX logo
Compass Therapeutics (CMPX)
LFCR logo
Lifecore Biomedical (LFCR)
HUMA logo
Humacyte (HUMA)
CERS logo
Cerus (CERS)
NRC logo
National Research (NRC)
  • What is the ticker symbol for iTeos Therapeutics?
  • Does iTeos Therapeutics pay dividends?
  • What sector is iTeos Therapeutics in?
  • What industry is iTeos Therapeutics in?
  • What country is iTeos Therapeutics based in?
  • When did iTeos Therapeutics go public?
  • Is iTeos Therapeutics in the S&P 500?
  • Is iTeos Therapeutics in the NASDAQ 100?
  • Is iTeos Therapeutics in the Dow Jones?
  • When was iTeos Therapeutics's last earnings report?
  • When does iTeos Therapeutics report earnings?
  • Should I buy iTeos Therapeutics stock now?

What is the ticker symbol for iTeos Therapeutics?

The ticker symbol for iTeos Therapeutics is NASDAQ:ITOS

Does iTeos Therapeutics pay dividends?

No, iTeos Therapeutics does not pay dividends

What sector is iTeos Therapeutics in?

iTeos Therapeutics is in the Healthcare sector

What industry is iTeos Therapeutics in?

iTeos Therapeutics is in the Biotechnology industry

What country is iTeos Therapeutics based in?

iTeos Therapeutics is headquartered in United States

When did iTeos Therapeutics go public?

iTeos Therapeutics's initial public offering (IPO) was on July 24, 2020

Is iTeos Therapeutics in the S&P 500?

No, iTeos Therapeutics is not included in the S&P 500 index

Is iTeos Therapeutics in the NASDAQ 100?

No, iTeos Therapeutics is not included in the NASDAQ 100 index

Is iTeos Therapeutics in the Dow Jones?

No, iTeos Therapeutics is not included in the Dow Jones index

When was iTeos Therapeutics's last earnings report?

iTeos Therapeutics's most recent earnings report was on Mar 5, 2025

When does iTeos Therapeutics report earnings?

The next expected earnings date for iTeos Therapeutics is May 9, 2025

Should I buy iTeos Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page